CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219,006 | -10.6% | 7,434 | -1.0% | 0.10% | -1.9% |
| Q2 2023 | $244,846 | -6.9% | 7,506 | +0.4% | 0.10% | -14.0% |
| Q1 2023 | $263,010 | -23.5% | 7,474 | -0.5% | 0.12% | -26.7% |
| Q4 2022 | $344,017 | -5.2% | 7,508 | +0.1% | 0.16% | -16.7% |
| Q3 2022 | $363,000 | +11.0% | 7,501 | -9.9% | 0.20% | +13.8% |
| Q2 2022 | $327,000 | +6.9% | 8,321 | 0.0% | 0.17% | +37.0% |
| Q1 2022 | $306,000 | -19.3% | 8,321 | 0.0% | 0.13% | -16.4% |
| Q4 2021 | $379,000 | +27.6% | 8,321 | 0.0% | 0.15% | +19.7% |
| Q3 2021 | $297,000 | -34.3% | 8,321 | -57.2% | 0.13% | +32.3% |
| Q1 2021 | $452,000 | – | 19,430 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |